Open access
Oct 2026
Genomic epidemiology of ceftazidime-avibactam-resistant, carbapenem-resistant Klebsiella pneumoniae in Henan Province, China
Ceftazidime-avibactam (CZA) is a key treatment for carbapenem-resistant Klebsiella pneumoniae (CRKP), but resistance is emerging rapidly in China. Henan is a CRKP epicenter, yet the genomic drivers of CZA resistance remain unclear. We conducted a multicenter genomic epidemiology study of 109 non-dupl...
Yi-Fei Wei, Le-Yin Zheng, Feng-Shuo Sun et al.
· BMC Microbiology · 0 citations